Five years after investors filed suit over loses they say were linked to the company failure to disclose illegal practices, Marsh & McLennan Co. has reached a settlement.
The possible end of bans on contingent commissions and New York’s proposal of new rules on broker compensation could lead to national and state regulatory changes affecting insurance sales.
New York’s recent steps to regulate contingent commissions could be a step toward relaxing a ban on the practice established four years ago, according to a report in the Wall Street Journal.
With the advent of the Supreme Court argument, all parties involved in the health insurance business are waiting. This is particularly true of health insurance carriers. Each insurance carrier to date has made adjustments to their business based on their best interpretation of the Patient Protection and Affordable Care Act, the federal health reform law.